drugset / Trial / NCT02248792
Quality of Life of Patients With Psoriasis Treated With Methotrexate: Prospective, Randomized, Double-blind, Parallel Group Study.
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Methotrexate (MTX) is considered the 'gold-standard' drug for the treatment of severe psoriasis. Health-related quality of life (HRQOL) is impaired in patients with psoriasis, more so if disease is severe.
Timeline
- Start
- 2013-11
- Primary completion
- 2015-01
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methotrexate | Small molecule | 10 mg | Oral |
| Subject | Methotrexate | Small molecule | 25 mg | Oral |